|

|

|

Showcase

>

Showcases
>
EAN 2020 | Teriflunomide shows benefits in children with relapsing forms of MS

05-25-2022
Neurology
Conference Coverage & Reporting

EAN 2020 | Teriflunomide shows benefits in children with relapsing forms of MS

Tanuja Chitnis tells us about the TERIKIDS study showing a numerical reduction in clinical relapse risk and a significant reduction in time to clinical relapse with teriflunomide in paediatric patients with relapsing-remitting multiple sclerosis (5:29).

Don’t fall behind!

Get the latest headlines – in your specialties of choice – delivered straight to your inbox.

Showcase

Real-world studies of SGLT2 inhibition and amputation risk

MEET THE SENIOR TEAM

Lucy Piper

medwireNews Bureau Chief

Related Showcases

|

Neurology

Unrestricted oral feedings reported by caregivers and affected persons across severity of…

Conference Coverage & Reporting

Neurology

Feasibility of assisted 6-minute cycle test shown in non-ambulatory SMA patients

Conference Coverage & Reporting

Neurology

Nusinersen treatment may improve aerobic capacity in adult SMA patients

Conference Coverage & Reporting

Neurology

Treatment linked to continued stabilization of motor function in adults with SMA

Conference Coverage & Reporting

Neurology

Study identifies miRNAs upregulated in SMA

Conference Coverage & Reporting

Oncology

Perioperative immunotherapy for NSCLC: Perspectives from an oncologist and a surgeon

Conference Coverage & Reporting

Building relationships through trusted content for healthcare professionals

A global leader in medical content

© 2023 Springer Healthcare Limited.
Part of the Springer Nature Group.